^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    BIOMARKER:

    FGFR1 mutation

    i
    Other names: FGFR1, BFGFR, CD331, CEK, FLG, FLT2, H2, H3, H4, H5, KAL2, N-SAM, Fibroblast growth factor receptor 1
    Entrez ID:
    2260
    Related biomarkers:
    Expression
    Mutation
    CNA
    Fusion
    Others
    1year
    Activity of Pemigatinib in Pilocytic Astrocytoma and FGFR1 N546K Mutation https://t.co/TFUmGJvvf7 (@VivekSubbiah)
    FGFR1 (Fibroblast growth factor receptor 1)
    |
    FGFR1 mutation
    |
    Pemazyre (pemigatinib)
    over1year
    ⭐️Activity of Pemigatinib in Pilocytic Astrocytoma and FGFR1 N546K Mutation https://t.co/MtXO5hNh79 (@VivekSubbiah)
    FGFR1 (Fibroblast growth factor receptor 1)
    |
    FGFR1 mutation
    |
    Pemazyre (pemigatinib)
    almost2years
    Activity of Pemigatinib in Pilocytic Astrocytoma and FGFR1 N546K Mutation @JCOPO_ASCO @OncoAlert https://t.co/ZTMuhGaHFs (@VivekSubbiah)
    FGFR1 (Fibroblast growth factor receptor 1)
    |
    FGFR1 mutation
    |
    Pemazyre (pemigatinib)
    almost2years
    Activity of Pemigatinib in Pilocytic Astrocytoma and FGFR1 N546K Mutation https://t.co/iohL3nwSC1 (@VivekSubbiah)
    FGFR1 (Fibroblast growth factor receptor 1)
    |
    FGFR1 mutation
    |
    Pemazyre (pemigatinib)
    almost2years
    🎯🧬Activity of Pemigatinib in Pilocytic Astrocytoma and FGFR1 N546K Mutation https://t.co/YItXLXO6yJ (@VivekSubbiah)
    FGFR1 (Fibroblast growth factor receptor 1)
    |
    FGFR1 mutation
    |
    Pemazyre (pemigatinib)
    almost2years
    ⭐️Activity of Pemigatinib in Pilocytic Astrocytoma and FGFR1 N546K Mutation @JCOPO_ASCO https://t.co/rx2Q1IHlrI (@VivekSubbiah)
    FGFR1 (Fibroblast growth factor receptor 1)
    |
    FGFR1 mutation
    |
    Pemazyre (pemigatinib)
    almost2years
    ⭐️Activity of Pemigatinib in Pilocytic Astrocytoma and FGFR1 N546K Mutation 🧬🎯@JCOPO_ASCO #BrainTumorAwarenessMonth @OncoAlert https://t.co/MKufdJmW9p (@VivekSubbiah)
    FGFR1 (Fibroblast growth factor receptor 1)
    |
    FGFR1 mutation
    |
    Pemazyre (pemigatinib)
    almost2years
    ⭐️Activity of Pemigatinib in Pilocytic Astrocytoma and FGFR1 N546K Mutation https://t.co/W4Ch7h3jhk (@VivekSubbiah)
    FGFR1 (Fibroblast growth factor receptor 1)
    |
    FGFR1 mutation
    |
    Pemazyre (pemigatinib)
    almost2years
    🚨⭐️Hot off the press in time for #BrainTumorAwarenessMonth 👉🏼Activity of Pemigatinib in Pilocytic Astrocytoma & FGFR1 N546K Mutation #PrecisionMedicine 🧬🎯! Loved working w budding future neurology resident @stephencaponemd @JCOPO_ASCO @OncoAlert https://t.co/HinpzGGpIn (@VivekSubbiah)
    FGFR1 (Fibroblast growth factor receptor 1)
    |
    FGFR1 mutation
    |
    Pemazyre (pemigatinib)
    over2years
    Any ongoing clinical trials recruiting patients with colorectal cancer KRAS G12C mutations or FGFR1 amplifications? @weoncologists @BenWestphalen @tmprowell @PTarantinoMD @VivekSubbiah (@bin_abeid)
    Clinical
    |
    KRAS (KRAS proto-oncogene GTPase) • FGFR1 (Fibroblast growth factor receptor 1)
    |
    KRAS mutation • KRAS G12C • FGFR1 amplification • FGFR1 mutation • KRAS G12